
Integrated DNA Technologies and SeQure Dx Enter Licensing Agreement to Enhance CRISPR-Based Therapeutics
Integrated DNA Technologies (IDT), a global leader in CRISPR genome editing solutions, has entered into a licensing agreement with SeQure Dx, a company specializing in off-target analysis for gene modification customers. This agreement enhances IDT’s CRISPR portfolio, offering comprehensive solutions…












